Skip to main content
SpringerLink
Log in

Cambiamento dell’isotipo di componenti monoclonali note: due casi clinici

Isotype change of monoclonal components: two clinical cases

  • Lettera
  • Published:
La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Bibliografia

  1. Ruggeri M, Bottan F, Chiarugi P et al. (2001) Linee guida per la diagnostica ed il monitoraggio delle gammapatie monoclonali. Riv Med Lab-JLM 2(S1):68–71

    Google Scholar 

  2. Caldini A, Graziani MS, Basile U et al. (2014) Il contributo della diagnostica proteica nella gestione delle gammapatie monoclonali. Biochimica Clinica 38:47–53

    Google Scholar 

  3. Dimopoulos M, Kyle R, Fermand JP et al. (2011) Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3. Blood 117:4701–4705

    Article  CAS  PubMed  Google Scholar 

  4. Kyle RA, Durie BG, Rajkumar SV et al. (2010) Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 24:1121–1127

    Article  CAS  PubMed  Google Scholar 

  5. Berenson JR, Anderson KC, Audell RA et al. (2010) Monoclonal gammopathy of undetermined significance: a consensus statement. Br J Haematol 150:28–38

    PubMed  Google Scholar 

  6. Bird J, Behrens J, Westin J et al. (2009) UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol 147:22–42

    Article  CAS  PubMed  Google Scholar 

  7. Durie BG, Harousseau JL, Miguel JS et al. (2006) International uniform response criteria for multiple myeloma. Leukemia 20:1467–1473

    Article  CAS  PubMed  Google Scholar 

  8. Wadhera RK, Kyle RA, Larson DR et al. (2011) Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma. Blood 118:2985–2987

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kyle RA, Therneau TM, Rajkumar SV et al. (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346:564–569

    Article  PubMed  Google Scholar 

  10. Rajkumar SV, Kyle RA, Therneau TM et al. (2005) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 106:812–817

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Turesson I, Kovalchik SA, Pfeiffer RM et al. (2014) Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. Blood 123:338–345

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. DAI Medicina di Laboratorio, Azienda Sanitaria Universitaria Integrata, Trieste, Italia

    Maria Paola Simula, Annalisa Fabris & Maurizio Ruscio

  2. Ematologia Clinica, Azienda Sanitaria Universitaria Integrata, Trieste, Italia

    Gianluca Festini

Authors
  1. Maria Paola Simula
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Annalisa Fabris
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gianluca Festini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maurizio Ruscio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Paola Simula.

Ethics declarations

Conflitti di interesse

Nessuno.

Studi condotti su esseri umani e animal

Per questo tipo di studio non è richiesto l’inserimento di alcuna dichiarazione relativa agli studi effettuati su esseri umani e animali.

Consenso informato

Il consenso informato è stato ottenuto da tutti i pazienti inclusi nello studio.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Simula, M.P., Fabris, A., Festini, G. et al. Cambiamento dell’isotipo di componenti monoclonali note: due casi clinici. Riv Ital Med Lab 12, 252–255 (2016). https://doi.org/10.1007/s13631-016-0133-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13631-016-0133-7

Search

Navigation